MedTrace Logo

Antidiabetic Properties of Rose Hip

NCT01316016 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2011-03-16

No results posted yet for this study

Summary

The purpose of this study is to determine whether daily intake of a drink containing rose hip powder reduces risk markers of type diabetes and cardiovascular disease.

Conditions

Interventions

DIETARY_SUPPLEMENT

Rose hip

40 g of rose hip powder daily for 6 weeks.

Sponsors & Collaborators

  • Lund University

    lead OTHER

Principal Investigators

  • Per Katzman, MD/PhD · Lund University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-02-28
Completion
2011-01-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01316016 on ClinicalTrials.gov